US Patent 9873894 Methods and compositions for treatment of a genetic condition
Patent 9873894 was granted and assigned to Sangamo Therapeutics on January, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9873894 Methods and compositions for treatment of a genetic condition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.